RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > China's Communist Party Calls for Reforms to Drug Regulatory System

China's Communist Party Calls for Reforms to Drug Regulatory System

Posted 19 November 2012 | By Ansis Helmanis

China's Communist party has called for the comprehensive reform of its food and drug regulatory system in order to respond to the concerns of its people, part of a group of reforms called for at a 16 November 2012 meeting of the Communist Party of China's National People's Congress.

The focus of the called-for reforms is on improving food and drug safety and the institutional regulatory mechanisms that are tasked with that mandate, explained China's State Food and Drug Administration (SFDA), which was a part of the meeting by way of a study group. 

Yin Li, the Commissioner of the State Food and Drug Administration (SFDA), noted at the meeting that the SFDA must fully grasp the Party's major new requirements for drug supervision work.

Moreover, Yin Li said SFDA's drug supervision work should focus on accelerating the supervision of a new mechanism adapted to establish and improve economic and social development and address people's health needs. Finally, there is the need to ensure honest government and to do the regulatory work in a realistic and pragmatic manner, he said.


Read more:

SFDA - National Bureau party central group to study and implement the spirit of the Party (Han Chinese)

Read all Breaking News from RegLink


Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.